Latest News

Heron (HRTX) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 26, 2026

ServiceNow and Salesforce look well-positioned for the AI age despite how their stocks have been performing.
Via The Motley Fool · February 26, 2026

CoreCivic manages correctional and reentry facilities across the U.S., providing outsourced solutions for government agencies.
Via The Motley Fool · February 26, 2026

Ligand Pharma (LGND) Earnings Call Transcript
Via The Motley Fool · February 26, 2026
Although GICs are popular for their safety, these three reliable Canadian dividend stocks are far better to buy for passive income seekers.
Via The Motley Fool · February 26, 2026
Here's why this impressive Canadian growth stock is undoubtedly the best investment to buy whenever its shares pullback.
Via The Motley Fool · February 26, 2026
3D design software company Autodesk (NASDAQ:ADSK) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 19.4% year on year to $1.96 billion. Guidance for next quarter’s revenue was optimistic at $1.89 billion at the midpoint, 2.9% above analysts’ estimates. Its non-GAAP profit of $2.85 per share was 7.8% above analysts’ consensus estimates.
Via StockStory · February 26, 2026

Integra LifeSciences (IART) Earnings Transcript
Via The Motley Fool · February 26, 2026

This analog semiconductor firm serving global data centers and industry just reported a notable insider sale, SEC filings show.
Via The Motley Fool · February 26, 2026
Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 44.4% year on year to $1.01 billion. On the other hand, next quarter’s revenue guidance of $1.22 billion was less impressive, coming in 1.9% below analysts’ estimates. Its GAAP loss of $0.05 per share was 67.1% above analysts’ consensus estimates.
Via StockStory · February 26, 2026

Kymera (KYMR) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 26, 2026

KBR (KBR) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 26, 2026
Fintech mortgage provider Rocket Companies (NYSE:RKT) announced better-than-expected revenue in Q4 CY2025, with sales up 127% year on year to $2.69 billion. On top of that, next quarter’s revenue guidance ($2.7 billion at the midpoint) was surprisingly good and 15.9% above what analysts were expecting. Its non-GAAP profit of $0.11 per share was 26.7% above analysts’ consensus estimates.
Via StockStory · February 26, 2026
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 6.7% year on year to $318.4 million. On the other hand, next quarter’s revenue guidance of $325.5 million was less impressive, coming in 5.1% below analysts’ estimates. Its non-GAAP profit of $0.48 per share was 19.9% above analysts’ consensus estimates.
Via StockStory · February 26, 2026
Here's why Fortis (TSX:FTS) still looks like one of the best opportunities in the market right now for long-term investors seeking total returns.
Via The Motley Fool · February 26, 2026
Investors looking to beat the market this year have plenty of opportunities to choose from, but these three could be the best right now.
Via The Motley Fool · February 26, 2026
Meta Platforms is trading at recent low valuation levels.
Via The Motley Fool · February 26, 2026
Circle's blockchain-based ecosystem for stablecoin payments is expanding.
Via The Motley Fool · February 26, 2026

Nautilus (NAUT) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 26, 2026

This national homebuilder, known for its integrated approach to residential construction and services, just reported a notable insider sale.
Via The Motley Fool · February 26, 2026
Investors who are looking for top-tier, blue-chip opportunities among the plethora of AI stocks that are available out there have three excellent TSX stocks to pick from.
Via The Motley Fool · February 26, 2026

Investors looking for world-class opportunities with truly incredible long-term upside have come to the right place – here are three great picks.
Via The Motley Fool · February 26, 2026
The weight-loss drug innovator is falling behind in the industry and facing major pricing pressures.
Via The Motley Fool · February 26, 2026

Payoneer (PAYO) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 26, 2026

Playtika (PLTK) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 26, 2026